|
|
|
| Director : HEARD Jean Michel (jmheard@pasteur.fr) |
 |
The laboratory is for one part involved in the development of strategies for gene therapy. Investigated models are principally the correction of ß-thalassemia and the correction of neurodegenerative lesions associated to lysosomal storage diseases. Vector derived from lentiviruses or AAV are used. Another part of the laboratory is interested in cell-retroviruses interactions, especially focusing on very early stages involving receptors, leading to virus entry and antigen presentation. The role of the HIV Nef protein is studied in this context. |
 |
 |
No english version |
 |
 |
Publications of the unit on Pasteur's references database |
 |
| Office staff | Researchers | Scientific trainees | Other personnel | |
|
Renée Communal, communal@pasteur.fr |
Olivier Schwartz CR Institut Pasteur schwartz@pasteur.fr Delphine Bohl CR2 INSERM dbohl@pasteur.fr Nathalie Sol-Foulon CR2 CNRS natsol@pasteur.fr Sylvie Le Gall CR2 INSERM |
Arnaud Moris Stage post-doctoral moris@paseur.fr Song Liu Stage post-doctoral songliu@pasteur.fr Christine Salaün Thèse Ecole Doctorale B2M csalaun@pasteur.fr Emmanuel Gyan Etudiant DEA egyan@pasteur.fr Cinzia Nobile Etudiante étrangère nobileci@pasteur.fr |
Valérie Maréchal Technicienne Supérieure 2D marechal@pasteur.fr Nathalie Desmaris Technicienne Supérieure 1D nchodan@pasteur.fr |
